Prior activation of protein kinase C (PKC) can precondition the cardiac cel
l against injury during subsequent ischaemia. By using cultured chick ventr
icular cell model for simulated ischaemia and preconditioning, the present
study investigated the biochemical mechanism underlying the PKC-mediated pr
econditioning. A 5 min exposure to PMA enhanced the ability of pinacidil to
mediate cardioprotection during a subsequent 90 min period of ischaemia, w
hich is consistent with a sustained activation of the K-ATP channel initiat
ed by PKC, The brief prior exposure to PMA was also associated with an enha
nced ability of the adenosine A(1) or A(3) receptor agonist 2-chloro-N-6-cy
clopentyladenosine or N-6-(3-iodobenzyl)adenosine-5'-N-methyluronamide to e
licit a cardioprotective response during the subsequent ischaemia. In myocy
tes pretreated with PMA, the cardioprotection mediated by receptor agonist
was blocked by the concomitant presence of K-ATP-channel antagonists gliben
clamide or 5-hydroxydecanoic acid during the ischaemia. Thus the K-ATP chan
nel acts downstream of the adenosine A, and A, receptors in mediating the p
rotective effect due to prior PMA exposure. K-ATP channel activation is res
ponsible for the adenosine receptor-mediated effect. PMA treatment had no e
ffect on other A(1) or A(3) receptor-mediated effects such as the inhibitio
n of adenylate cyclase, ruling out a direct stimulation of the receptor or
G-protein by PMA, The present results indicate that prior stimulation of PK
C causes a sustained K-ATP channel activation, which in turn renders the my
ocyte more responsive to the protective action of adenosine A, and A, recep
tor agonists during the subsequent ischaemia.